Visit DEMGY Group Booth 4664
SAINT-AUBIN-SUR-GAILLON,
France, July 23,
2024 /PRNewswire/ -- DEMGY Group, an international
technology group specializing in innovative plastics processing,
produces high-precision medical devices using high-performance
materials. With 4 ISO 13485 medically certified manufacturing sites
in France and the USA, 3 R&D centers and 4 ISO 7 & 8
cleanrooms, DEMGY supports its customers from eco-design to the
manufacture, assembly and packaging of new medical devices.
√ Presentation of innovative "microfluidic" technology for
lab-on-a-chip production using micro-injection molding.
DEMGY has the capacity to industrialize the manufacture of
customized microfluidic devices: lab-on-a-chip, biochips, mTas,
microfluidic cartridges... They all feature a combination of
characteristics, microstructures linked by microchannels to fulfill
an analytical function.
Miniature features measuring just a few microns can be
integrated into the cartridge - reservoirs, micro-pillars, valves -
to enable functions such as sample splitting, spacing or
mixing.
Microfluidic plates manufactured by DEMGY can be connected,
fitted with through-holes and even interact with other devices by
equipping the chip with an integrated sensor to measure pH or
temperature, for example.
√ Medical devices are injected and assembled in clean rooms
DEMGY is equipped with 4 state-of-the-art ISO 7 and ISO 8
cleanrooms, in which medical devices are injection molded and
assembled.
About DEMGY :
Founded in 1947, DEMGY Group, an international technology group
in innovative plastics processing, designs and manufactures
high-performance plastic and composite solutions that are lighter
than metal, to promote energy savings. DEMGY Group is actively
involved in the process of decarbonizing industry.
Its circular Multiplasturgy® offering, a one-stop shop for its
15 areas of expertise, starts with eco-design, which enables
upstream management of the end-of-life of products and their
recyclability.
The Group has 5 sites in France, 2 in Germany, 2 in Romania and 1 in the
United States, as well as 3 R&D centers and 2 sales
offices in the UK and Israel.
In 2023, DEMGY Group generated sales of 100 million euros, 7% of which was invested in
R&D and capital expenditure.
DEMGY Group employs over 800 people.
Contact:
Mike Walter
Division President of DEMGY Chicago
m.walter@demgy.com
+1 847 456 4562
Photo -
https://mma.prnewswire.com/media/2467401/Demgy_Frasne.jpg
Photo -
https://mma.prnewswire.com/media/2467400/Demgy_Chicago.jpg
Photo -
https://mma.prnewswire.com/media/2467399/Demgy_Lab_on_a_chip.jpg
Logo - https://mma.prnewswire.com/media/2467402/DEMGY_Logo.jpg
View original content to download
multimedia:https://www.prnewswire.com/news-releases/demgy-group-presents-its-innovations-in-the-medical-sector-at-adlm-chicago-july-28---august-1er-2024-302204075.html
SOURCE DEMGY Group